rs142007575
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000435.3(NOTCH3):c.6031G>A(p.Val2011Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,612,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000435.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOTCH3 | NM_000435.3 | c.6031G>A | p.Val2011Ile | missense_variant | 33/33 | ENST00000263388.7 | NP_000426.2 | |
NOTCH3 | XM_005259924.5 | c.5875G>A | p.Val1959Ile | missense_variant | 32/32 | XP_005259981.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOTCH3 | ENST00000263388.7 | c.6031G>A | p.Val2011Ile | missense_variant | 33/33 | 1 | NM_000435.3 | ENSP00000263388.1 | ||
NOTCH3 | ENST00000595514.1 | n.*239G>A | downstream_gene_variant | 3 | ENSP00000470661.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000189 AC: 46AN: 243792Hom.: 0 AF XY: 0.000196 AC XY: 26AN XY: 132346
GnomAD4 exome AF: 0.000195 AC: 284AN: 1459746Hom.: 0 Cov.: 36 AF XY: 0.000189 AC XY: 137AN XY: 726006
GnomAD4 genome AF: 0.000131 AC: 20AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74480
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | NOTCH3: PP2, BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 17, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 28, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at